HBLVX
Price
$15.00
Change
-$0.00 (-0.00%)
Updated
Aug 5 closing price
Net Assets
11.83B
RMYSX
Price
$9.83
Change
-$0.00 (-0.00%)
Updated
Aug 5 closing price
Net Assets
290.46M
Interact to see
Advertisement

HBLVX vs RMYSX

Header iconHBLVX vs RMYSX Comparison
Open Charts HBLVX vs RMYSXBanner chart's image
Hartford Balanced Income R6
Price$15.00
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.83B
Russell Inv Multi-Strategy Income S
Price$9.83
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets290.46M
HBLVX vs RMYSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HBLVX vs. RMYSX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLVX is a Buy and RMYSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLVX has more cash in the bank: 11.8B vs. RMYSX (290M). RMYSX pays higher dividends than HBLVX: RMYSX (5.68) vs HBLVX (3.61). HBLVX was incepted earlier than RMYSX: HBLVX (11 years) vs RMYSX (10 years). RMYSX (0.92) is less costly to investors than HBLVX (0.56). RMYSX is a more actively managed with annual turnover of: 88.00 vs. HBLVX (61.00). HBLVX (0) and RMYSX (0) have matching initial minimum investment requirements. RMYSX annual gain was more profitable for investors over the last year : 8.98 vs. HBLVX (5.36). RMYSX return over 5 years is better than : 19.00 vs. HBLVX (15.65).
HBLVXRMYSXHBLVX / RMYSX
Total Expense Ratio0.560.7575%
Annual Report Gross Expense Ratio0.560.9261%
Fund Existence11 years10 years-
Gain YTD6.1907.77280%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B290M4,069%
Annual Yield % from dividends3.615.6864%
Returns for 1 year5.368.9860%
Returns for 3 years13.6720.8865%
Returns for 5 years15.6519.0082%
Returns for 10 years45.0536.10125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSUMX14.150.02
+0.14%
Thornburg Summit I
FPHAX24.34N/A
N/A
Fidelity Select Pharmaceuticals Port
AVLVX14.70N/A
N/A
Avantis U.S. Large Cap Value Inst
JLPCX16.28N/A
N/A
JPMorgan US Large Cap Core Plus C
TCEPX44.13N/A
N/A
Nuveen Equity Index Premier